Indian Gliclazide Exporters: Complete Supplier Ranking with Market Share — 643 Manufacturers (2026) — TransData Nexus

Q: Who is the largest gliclazide buyer importing from India?

MYLAN HUNGARY KFT, (HUNGARY) is the largest gliclazide importer from India with a 28.9% market share and import value of $87.1M.

Q: How many gliclazide buyers import from India?

There are 643 active gliclazide buyers importing from India, with a combined import market of $300.8M across 3,830 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top gliclazide buyers from India?

The top 5 gliclazide buyers — MYLAN HUNGARY KFT,, DANANG PHARMACEUTICAL MEDICAL EQUIP, TORRENT DO BRASIL LTDA, MYLAN PHARMACEUTICALS ULC, DELTA IMPORT EXPORT MEDICAL CO., LT — together control 44.0% of total gliclazide import value from India.

Suresh Sormare

Gliclazide

India Pharmaceutical Trade Intelligence

$300.8M238 Suppliers109 CountriesHS 30049099

ExportsIndia → HUNGARY29.3%India → NETHERLANDS29.2%

ImportsUNITED KINGDOM → India$1.0M BULGARIA → India$261.6K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN HUNGARY

Market Analysis: Top Importing Countries & Their Importers

1Hungary

Hungary emerges as the first largest importing country, achieving a total trade value of $88.2M through 21 shipments. This represents a market share of 29.3% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Hungary has a diverse importer base, with their top importers including:

• MYLAN HUNGARY KFT, - $87.1M (98.8% of country's total business)

Key Insight: Hungary demonstrates strong market positioning with an average shipment value of $4.2M, indicating premium pricing strategy compared to the market average of $78.5K.

Hungary is a key market for Gliclazide imports, representing 29.3% of total trade value.

Primary Market

Secondary Market

2Netherlands

Netherlands emerges as the second largest importing country, achieving a total trade value of $87.7M through 0 shipments. This represents a market share of 29.2% of the total market activity, demonstrating their significant presence in the industry.

Buyer Segment Analysis

TransData Nexus Gliclazide buyer market intelligence

1Buyer Segment Analysis

The importation of Gliclazide from India involves various buyer segments, each with distinct purchasing behaviors:

Distributors: Entities like MYLAN HUNGARY KFT (Hungary) and FIEGE HEALTHCARE LOGISTICS GMBH (Germany) function as intermediaries, procuring large quantities to supply regional markets. Their purchasing patterns are characterized by bulk orders to ensure consistent supply chains.

Contract Manufacturers: Companies such as TORRENT DO BRASIL LTDA (Brazil) and RANBAXY FARMACEUTICA LTDA (Brazil) import Gliclazide for formulation and packaging under their brand names. Their procurement is aligned with production schedules and market demand forecasts.

Government Procurement Agencies: Entities like CENTRAL PHARMACEUTICAL JOINT STOCK (Vietnam) and DELTA IMPORT EXPORT MEDICAL CO., LTD (Vietnam) are involved in national tenders to supply public healthcare facilities. Their purchasing is influenced by government healthcare policies and budget allocations.

Retail Chains and Hospital Groups: Organizations such as MEDREICH PLC (United Kingdom) and MYLAN PHARMACEUTICALS ULC (Canada) procure Gliclazide to meet the needs of their retail outlets and affiliated hospitals. Their orders are typically based on patient demand and inventory turnover rates.

Country-Specific Import Regulations

TransData Nexus Gliclazide buyer market intelligence

1Country-Specific Import Regulations

The top five importing countries have specific regulatory frameworks for Gliclazide:

Hungary:
Regulatory Authority: National Institute of Pharmacy and Nutrition (OGYÉI).
Import Registration: Requires submission of a marketing authorization application, including quality, safety, and efficacy data.
Timeline: Approximately 210 days.
Import Tariff: Pharmaceutical products under HS Code 30049099 are generally exempt from import duties within the EU.

Netherlands:
Regulatory Authority: Medicines Evaluation Board (CBG-MEB).
Import Registration: Submission of a marketing authorization dossier in line with EU directives.

Demand Drivers & Market Opportunity

TransData Nexus Gliclazide buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Gliclazide is primarily driven by the global prevalence of type 2 diabetes, which has been increasing steadily. According to the International Diabetes Federation, as of 2025, approximately 578 million adults worldwide are living with diabetes, with type 2 diabetes accounting for the majority of cases. This rising prevalence underscores the need for effective oral hypoglycemic agents like Gliclazide.

Government healthcare programs and the expansion of universal health coverage have also significantly influenced demand. Many countries have included Gliclazide in their national essential medicines lists, aligning with the World Health Organization's Model List of Essential Medicines, which recommends Gliclazide for the management of type 2 diabetes. Additionally, tender-based procurement systems are prevalent, especially in low- and middle-income countries, facilitating bulk purchasing and ensuring wider accessibility. The presence of 643 buyers across 109 countries, as per our data, reflects the extensive global reach and market opportunity for Gliclazide.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Gliclazide Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest gliclazide buyer importing from India?

Based on import volume and value, MYLAN HUNGARY KFT, (HUNGARY) leads with $87.1M in imports and a 28.9% market share — the highest of any single gliclazide importer. DANANG PHARMACEUTICAL MEDICAL EQUIP (VIETNAM) and TORRENT DO BRASIL LTDA (BRAZIL) are the next largest buyers.

QHow many companies buy gliclazide from India?

There are 643 active gliclazide buyers importing from India, with a combined market of $300.8M across 3,830 shipments to 109 countries. The top 5 buyers hold 44.0% of total import value, while the remaining 638 buyers handle the other 56.0%.

QWhich countries import the most gliclazide from India?

The top importing countries for gliclazide from India are Hungary (29.3%), Netherlands (29.2%), Vietnam (13.9%), Brazil (6.9%), Philippines (2.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of gliclazide, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for gliclazide from India?

The average import transaction value for gliclazide from India is $78.5K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Gliclazide buyer market intelligence

1Buyer Segment Analysis

The importation of Gliclazide from India involves various buyer segments, each with distinct purchasing behaviors:

Distributors: Entities like MYLAN HUNGARY KFT (Hungary) and FIEGE HEALTHCARE LOGISTICS GMBH (Germany) function as intermediaries, procuring large quantities to supply regional markets. Their purchasing patterns are characterized by bulk orders to ensure consistent supply chains.

Contract Manufacturers: Companies such as TORRENT DO BRASIL LTDA (Brazil) and RANBAXY FARMACEUTICA LTDA (Brazil) import Gliclazide for formulation and packaging under their brand names. Their procurement is aligned with production schedules and market demand forecasts.

Government Procurement Agencies: Entities like CENTRAL PHARMACEUTICAL JOINT STOCK (Vietnam) and DELTA IMPORT EXPORT MEDICAL CO., LTD (Vietnam) are involved in national tenders to supply public healthcare facilities. Their purchasing is influenced by government healthcare policies and budget allocations.

Retail Chains and Hospital Groups: Organizations such as MEDREICH PLC (United Kingdom) and MYLAN PHARMACEUTICALS ULC (Canada) procure Gliclazide to meet the needs of their retail outlets and affiliated hospitals. Their orders are typically based on patient demand and inventory turnover rates.

Country-Specific Import Regulations

TransData Nexus Gliclazide buyer market intelligence

1Country-Specific Import Regulations

The top five importing countries have specific regulatory frameworks for Gliclazide:

Hungary:
Regulatory Authority: National Institute of Pharmacy and Nutrition (OGYÉI).
Import Registration: Requires submission of a marketing authorization application, including quality, safety, and efficacy data.
Timeline: Approximately 210 days.
Import Tariff: Pharmaceutical products under HS Code 30049099 are generally exempt from import duties within the EU.

Netherlands:
Regulatory Authority: Medicines Evaluation Board (CBG-MEB).
Import Registration: Submission of a marketing authorization dossier in line with EU directives.

Demand Drivers & Market Opportunity

TransData Nexus Gliclazide buyer market intelligence

1Demand Drivers & Market Opportunity

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Gliclazide

Gliclazide

Who Buys Gliclazide from India — 643 Importers Behind a $300.8M Market

Top Gliclazide Importers — Ranked by Import Value

Top Gliclazide Buyers & Importers

Related Analysis

Need Details?

Gliclazide — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Gliclazide — and from which countries?

Gliclazide — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1Hungary

2Netherlands

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Gliclazide Buyers & Importers

QWho is the largest gliclazide buyer importing from India?

QHow many companies buy gliclazide from India?

QWhich countries import the most gliclazide from India?

QWhat is the average import order value for gliclazide from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Vietnam

4Brazil

5Philippines

Analysis Methodology